Article info

Download PDFPDF
Supplement
Janus kinase inhibitors in autoimmune diseases

Authors

  • John J O'Shea Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Apostolos Kontzias Pediatric Rheumatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Kunihiro Yamaoka The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan PubMed articlesGoogle scholar articles
  • Yoshiya Tanaka The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan PubMed articlesGoogle scholar articles
  • Arian Laurence Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence toDr John J O'Shea, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892-1930, USA; osheajo{at}mail.nih.gov
View Full Text

Citation

O'Shea JJ, Kontzias A, Yamaoka K, et al
Janus kinase inhibitors in autoimmune diseases

Publication history

  • Received August 28, 2012
  • Revised January 21, 2013
  • Accepted January 29, 2013
  • First published March 25, 2013.
Online issue publication 
March 25, 2013

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.